Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

BACKGROUND: Low-dose glucocorticoid (GC) therapy is widely used in rheumatoid arthritis (RA) but the balance of benefit and harm is still unclear. METHODS: The GLORIA (Glucocorticoid LOw-dose in RheumatoId Arthritis) pragmatic double-blind randomised trial compared 2 years of prednisolone, 5 mg/day,...

Descripción completa

Detalles Bibliográficos
Autores principales: Boers, Maarten, Hartman, Linda, Opris-Belinski, Daniela, Bos, Reinhard, Kok, Marc R, Da Silva, Jose AP, Griep, Eduard N, Klaasen, Ruth, Allaart, Cornelia F, Baudoin, Paul, Raterman, Hennie G, Szekanecz, Zoltan, Buttgereit, Frank, Masaryk, Pavol, Klausch, L Thomas, Paolino, Sabrina, Schilder, Annemarie M, Lems, Willem F, Cutolo, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209692/
https://www.ncbi.nlm.nih.gov/pubmed/35641125
http://dx.doi.org/10.1136/annrheumdis-2021-221957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209692/
https://www.ncbi.nlm.nih.gov/pubmed/35641125
http://dx.doi.org/10.1136/annrheumdis-2021-221957

Ejemplares similares